Heron Therapeutics (HRTX) Interest Expenses (2012 - 2017)

Heron Therapeutics has reported Interest Expenses for 6 years, with the latest figure at $100000.0 in Q1 2017.

• For the quarter ending Q1 2017, Interest Expenses changed 0.0% year-over-year to $100000.0; the trailing twelve-month figure through Dec 2017 stood at $100000.0 (down 96.02% YoY), and the FY2025 full-year result was $9.6 million, up 59.23% from the prior year.
• Interest Expenses for Q1 2017 stood at $100000.0, down from $1.3 million in the prior quarter.
• The five-year high for Interest Expenses was $1.3 million in Q4 2016, with the low at -$377000.0 in Q4 2014.
• Historically, Interest Expenses has averaged $267705.9 across 5 years, with a median of $220000.0 in 2014.
• Annual changes were most pronounced in 2014 — Interest Expenses tumbled 277.83% — and 2016, when it jumped 414.17%.
• Heron Therapeutics' Interest Expenses stood at $212000.0 in 2013, then plunged by 277.83% to -$377000.0 in 2014, then soared by 165.52% to $247000.0 in 2015, then jumped by 414.17% to $1.3 million in 2016, then tumbled by 92.13% to $100000.0 in 2017.
• The last three Interest Expenses figures came in at $100000.0 (Q1 2017), $1.3 million (Q4 2016), and $886000.0 (Q3 2016), per Business Quant data.